Recent advances and future perspectives in non-small cell lung cancer immunotherapy
The introduction of immune checkpoint inhibitors has transformed therapeutic strategies for non-small cell lung cancer; however, the generalisation of data regarding their molecular mechanisms of action and predictors of therapeutic efficacy remains an important challenge. The aim of this study was to conduct a compreh...